The oil-water partition coefficient (log P) is a fundamental physicochemical parameter that characterizes the lipophilicity, permeability, and absorption behavior of active pharmaceutical ingredients (APIs). Professional partition coefficient testing performed in accordance with OECD Test Guidelines 107, 117, and 123 delivers reliable data that support drug discovery, formulation development, and regulatory submissions. This article explains the technical principles, sample requirements, testing items, methodologies, and practical applications of API oil-water partition coefficient testing.
Technical Overview
The oil-water partition coefficient, most commonly determined between n-octanol and water, is defined as the ratio of a compound's equilibrium concentrations in the octanol phase and the aqueous phase: Pow = Coctanol / Cwater. Because Pow values span many orders of magnitude, the parameter is conventionally expressed as the base-10 logarithm, log P. A positive log P indicates preferential partitioning into the lipid-like octanol phase (lipophilic behavior), while a negative log P indicates hydrophilic behavior.
For ionizable compounds, a distinction is made between the partition coefficient (log P), which describes the neutral species, and the distribution coefficient (log D), which describes the apparent ratio at a defined pH where both ionized and unionized forms coexist. Both parameters are essential for predicting solubility, membrane permeability, oral absorption, tissue distribution, and formulation performance of an API.
Regulatory authorities and pharmacopoeial frameworks expect partition coefficient data as part of the physicochemical characterization of a drug substance, typically reported in CMC documentation (for example, section 3.2.S.3.1 of a regulatory dossier). Internationally recognized test procedures are defined in OECD Test Guideline 107 (shake-flask method), OECD Test Guideline 117 (HPLC method), and OECD Test Guideline 123 (slow-stirring method). Accredited third-party laboratories apply these harmonized guidelines together with analytical method validation principles outlined in ICH Q2 to ensure scientifically defensible results.
Testing Samples
Small-Molecule APIs and New Chemical Entities
Purified drug substances intended for preclinical evaluation, clinical trials, or commercial registration are the primary test articles. A minimum known purity of 95% or higher is recommended so that co-eluting impurities do not distort the measured phase concentrations.
Intermediates, Impurities, and Degradation Products
Synthetic intermediates, process-related impurities, and forced-degradation products are frequently characterized for lipophilicity during impurity profiling and structure-activity assessment, particularly when genotoxicity or safety qualification studies are required.
Salts, Free Acids, and Free Bases
Because salts dissociate in the aqueous phase, the neutral free acid or free base form is generally used for log P determination, while log D values at physiologically relevant pH values are determined for the salt form or the formulated drug substance.
Peptides, Oligonucleotides, and Semi-Volatile Compounds
For macromolecules and semi-volatile or unstable compounds, method adaptation is required; accredited third-party laboratories can tailor phase ratios, equilibration conditions, and quantification techniques to the specific molecular properties.
Typical sample requirements include 50 to 200 mg of test substance (as little as 10 to 20 mg for the HPLC method), a certificate of analysis or purity statement, the known or estimated pKa, solubility information, and safety handling data.
Testing Items
- Octanol-water partition coefficient (Pow) and logarithmic value (log P) of the neutral species
- Distribution coefficient (log D) at specified pH values, commonly pH 1.2, 4.5, 6.8, 7.4, or customer-defined buffers
- Concentration-independence verification performed at multiple phase ratios to confirm equilibrium behavior
- Mass balance assessment across both phases to confirm test validity
- Temperature-controlled determinations, typically at 20 to 25 degrees Celsius
- Complementary physicochemical characterization, including aqueous solubility, pKa, and pH-dependent behavior, when required
Testing Methods
Shake-Flask Method (OECD Test Guideline 107)
The shake-flask method is the reference direct-equilibration technique. Test vessels containing mutually saturated n-octanol and water (or buffer) phases are charged with the API, agitated until equilibrium is reached, and then allowed to separate by settling and centrifugation. Both phases are quantitatively analyzed using a validated method such as HPLC-UV, LC-MS/MS, or GC, and the Pow is calculated from the measured concentration ratio. The method is applicable over an approximate log P range of -2 to 4 and provides the highest data quality when phase ratios are optimized according to the expected partition behavior.
HPLC Method (OECD Test Guideline 117)
The chromatographic method correlates retention time on a reversed-phase HPLC system with lipophilicity. A calibration curve is established using reference compounds with well-documented log P values, and the retention factor of the test substance is interpolated to estimate its log P. This approach requires only microgram quantities of sample, avoids emulsion problems, and is well suited to compounds with log P values between 0 and 6, although it is most reliable for neutral molecules and should be justified carefully for ionizable compounds.
Slow-Stirring Method (OECD Test Guideline 123)
For highly hydrophobic substances with log P greater than approximately 5, the slow-stirring method minimizes the formation of octanol-in-water emulsions and adsorption artifacts. Gentle stirring is maintained for an extended period until equilibrium is achieved, after which both phases are analyzed. This method is recognized as the preferred approach for very lipophilic APIs and for environmental bioaccumulation assessments.
Quantification and Quality Control
All quantitative determinations are executed using analytical procedures validated in accordance with ICH Q2 principles, covering specificity, linearity, accuracy, precision, and detection capability. Duplicate or triplicate determinations, controlled temperature, protection from photodegradation, and confirmation that measured concentrations remain within the validated range of the analytical method are standard quality measures.
Applications
Partition coefficient data serve as decision-critical inputs throughout the pharmaceutical lifecycle.
- Drug discovery and lead optimization: log P is a core descriptor in Lipinski's Rule of Five and in QSAR models used to prioritize candidates with favorable developability profiles.
- ADME and permeability prediction: log D values at gastrointestinal pH correlate with passive membrane permeability and support interpretation of Caco-2 and PAMPA permeability studies.
- BCS classification and biowaiver support: lipophilicity data complement solubility and permeability datasets used to justify biopharmaceutics classification.
- Formulation development: partition behavior guides excipient selection, solubilization strategies, lipid-based delivery systems, and taste-masking design.
- Regulatory submissions: log P results are included in IND, NDA, ANDA, and CMC dossiers as part of the physicochemical characterization of the drug substance.
- Environmental risk assessment: log P values feed into bioconcentration and persistence screening conducted under OECD and regional environmental guidance frameworks.
FAQ
What is the difference between log P and log D?
log P describes the partitioning of only the neutral (unionized) form of a molecule between octanol and water, whereas log D describes the apparent distribution of all species present at a specified pH. For a non-ionizable compound, log P and log D are identical; for ionizable APIs, both parameters are usually needed to characterize behavior across physiological pH ranges.
Which testing method should be selected?
The shake-flask method is preferred when a direct, high-confidence determination is required and solubility permits. The HPLC method is chosen when sample quantity is limited or the compound is very lipophilic. The slow-stirring method is recommended for compounds with log P above 5. Method selection is confirmed during a technical review of the compound's structure, pKa, and solubility profile.
How much sample is required for testing?
Approximately 50 to 200 mg is typically sufficient for shake-flask studies, while the HPLC method may require only a few milligrams. Additional quantities are recommended when replicate pH conditions or method development work is anticipated.
At which pH values should log D be measured?
Common choices include pH 1.2 (gastric), pH 4.5 and 6.8 (intestinal), and pH 7.4 (physiological plasma). Clients may also specify buffers relevant to a particular route of administration or formulation strategy.
How long does the test take?
Standard shake-flask determinations are generally completed within one to two weeks, including equilibration verification and chromatographic analysis. Slow-stirring studies for highly lipophilic compounds may require additional equilibration time, while the HPLC method can often be completed faster.
Can the results be used for regulatory submissions?
Yes. Studies conducted by accredited third-party laboratories in compliance with OECD Test Guidelines 107, 117, or 123, supported by ICH-validated analytical methods and comprehensive reporting, are widely accepted by regulatory authorities worldwide for CMC and environmental assessment purposes.